Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis (Q35681597)

9 August 2017

1 reference

title

Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis (English)

1 reference

9 August 2017

0 references

1 reference

2

Lissy Jarvik

1 reference

9 August 2017

Natalie Rasgon

1

1 reference

PubMed ID

14999034

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

The Journals of Gerontology

9 August 2017

1 reference

9 August 2017

59

1 reference

9 August 2017

2

1 reference

9 August 2017

178-83; discussion 184-92

1 reference

Conditioning and sensitisation in the longitudinal course of affective illness

9 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Cognitive impairment and cerebral structure by MRI in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

The temporal relationship between depressive symptoms and dementia: a community-based prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Insulin resistance after oral glucose tolerance testing in patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Differential response of plasma glucose, amino acids and nonesterified fatty acids to insulin in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Relative insulin insensitivity and cortisol secretion in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

The brain-lipid-heart connection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Affective disorders and Alzheimer disease: a missing-link hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Diabetes mellitus in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Abnormalities in glucose regulation associated with mental illness and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Levels and risks of depression and anxiety symptomatology among diabetic adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Enhancing central and peripheral insulin activity as a strategy for the treatment of endogenous depression--an adjuvant role for chromium picolinate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Memory improvement following induced hyperinsulinemia in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Glucose intolerance, cognitive impairment and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Diabetes, Alzheimer's disease and apolipoprotein genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Left prefrontal glucose hypometabolism in the depressed state: a confirmation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

The renin angiotensin system and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Are psychoactive-drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiatric disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Epidemiological evidence for the association of hyperglycaemia and atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Fenfluramine increases insulin action in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Insulin inhibits pyramidal neurons in hippocampal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Psychiatric implications of basic and clinical studies with corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Depression, antidepressants, and the shrinking hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Acetylcholine and Depression*

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Regional cerebral blood flow in patients with affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Effects of cholinergic agonists on regional brain energy metabolism in the scopolamine-treated rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Raised glucose levels enhance scopolamine-induced acetylcholine overflow from the hippocampus: an in vivo microdialysis study in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Psychosocial factors and prognosis in established coronary artery disease. The need for research on interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Alzheimer disease as a vascular disorder: nosological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Depression as a risk factor for Alzheimer disease: the MIRAGE Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Six-month test-retest reliability of MRI-defined PET measures of regional cerebral glucose metabolic rate in selected subcortical structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Cingulate function in depression: a potential predictor of treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Subgenual prefrontal cortex abnormalities in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Brain metabolic changes associated with symptom factor improvement in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

A neuropathological study of vascular factors in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Perfusion abnormalities in prodromal AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Preclinical prediction of Alzheimer's disease using SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Tetanus-diphtheria immunizations in a nursing home population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Metformin for weight loss in pediatric patients taking psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

Pet Studies of Cerebral Function in Major Depression and Obsessive-CompulsiveDisorder: the Emerging Prefrontal Cortex Consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGERONA%2F59.2.M178

21 January 2018

Identifiers

DOI

10.1093/GERONA/59.2.M178

1 reference

9 August 2017

1 reference

PubMed ID

14999034